Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Fernando José Magro Dias

    Autor

  • Maria De Fátima Machado Henriques Carneiro

    Autor

Participantes de fora da FMUP

  • Rubin, David T.
  • Kubassova, Olga
  • Weber, Christopher R.
  • Adsul, Shashi
  • Freire, Marcelo
  • Biedermann, Luc
  • Koelzer, Viktor H.
  • Bressler, Brian
  • Xiong, Wei
  • Niess, Jan H.
  • Matter, Matthias S.
  • Kopylov, Uri
  • Barshack, Iris
  • Mayer, Chen
  • Maharshak, Nitsan
  • Greenberg, Ariel
  • Hart, Simon
  • Dehmeshki, Jamshid
  • Peyrin-Biroulet, Laurent

Unidades de investigação

Abstract

Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by increased stool frequency, rectal bleeding, and urgency. To streamline the quantitative assessment of histopathology using the Nancy Index in UC patients, we developed a novel artificial intelligence (AI) tool based on deep learning and tested it in a proof-of-concept trial. In this study, we report the performance of a modified version of the AI tool.Methods Nine sites from 6 countries were included. Patients were aged >= 18 years and had UC. Slides were prepared with hematoxylin and eosin staining. A total of 791 images were divided into 2 groups: 630 for training the tool and 161 for testing vs expert histopathologist assessment. The refined AI histology tool utilized a 4-neural network structure to characterize images into a series of cell and tissue type combinations and locations, and then 1 classifier module assigned a Nancy Index score.Results In comparison with the proof-of-concept tool, each feature demonstrated an improvement in accuracy. Confusion matrix analysis demonstrated an 80% correlation between predicted and true labels for Nancy scores of 0 or 4; a 96% correlation for a true score of 0 being predicted as 0 or 1; and a 100% correlation for a true score of 2 being predicted as 2 or 3. The Nancy metric (which evaluated Nancy Index prediction) was 74.9% compared with 72.3% for the proof-of-concept model.Conclusions We have developed a modified AI histology tool in UC that correlates highly with histopathologists' assessments and suggests promising potential for its clinical application. This multicenter study deployed an artificial intelligence tool based on machine learning to scan histopathology slides from ulcerative colitis biopsies and assign a Nancy Histopathology Index. The performance of the tool was similar to that of a panel of expert histopathologists.

Dados da publicação

ISSN/ISSNe:
1078-0998, 1536-4844

Inflammatory Bowel Diseases  Oxford University Press

Tipo:
Article
Páginas:
-
PubMed:
39284932

Citações Recebidas na Web of Science: 9

Citações Recebidas na Scopus: 9

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • ulcerative colitis; artificial intelligence; histopathology

Projetos associados

Gut microbiome and IBD therapy: an interplay?

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (GutIBD) . 2021

Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (IronIBD) . 2021

Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (4WARD) . 2021

The role of hepatocyte apoptosis markers in predicting the histological and serological activity in steatohepatitis

Investigador Principal: Maria de Fátima Machado Henriques Carneiro

Estudo Clínico Académico . 2021

Isolated Ulceration of Crohn’s Anastomosis

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2022

Burden of Inflammatory Bowel Disease in Portugal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico (Inflammatory Bowel) . 2023

Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Gastric Cancer Morphological, Immunophenotypic and molecular heterogeneity

Investigador Principal: Maria de Fátima Machado Henriques Carneiro

Estudo Clínico Académico . 2020

Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação